Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 179, 53-60
Abstract
No abstract availableKeywords
Funding Information
- Bowel Disease Research Foundation
This publication has 36 references indexed in Scilit:
- Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activityScientific Reports, 2013
- Neoadjuvant Therapy in Rectal CancerDiseases of the Colon & Rectum, 2011
- Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential RadiosensitizerMolecular Therapy, 2009
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancerHistopathology, 2005
- Postoperative complications in patients irradiated pre‐operatively for rectal cancer: report of a randomised trial comparing short‐term radiotherapy vs chemoradiationColorectal Disease, 2005
- Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment complianceEuropean Journal of Cancer, 2004
- From genomics to proteomicsNature, 2003
- Rectal CancerArchives of Surgery, 1998